Abstract
The diagnosis and treatment of thrombotic thrombocytopenic purpura (TTP) in patients following BMT are often uncertain and unsuccessful. To better understand the evaluation and management of these patients, we describe 17 patients treated with plasma exchange for a presumptive diagnosis of TTP following BMT during a 10 year period, 1989–1998. Because of the uncertainty of the diagnosis, these patients are described as having a ‘TTP-like syndrome’. All 17 patients had received an allogeneic BMT. Comparison with the other 245 patients who had an allogeneic BMT during the same period demonstrated that patients with a TTP-like syndrome more frequently had unrelated and/or HLA-mismatched donors, and had also experienced more serious complications: grade III–IV acute GVHD and systemic bacterial, fungal, and viral infections. Three months after the diagnosis of the TTP-like syndrome, only four of 17 patients (24%) were alive; currently only one patient survives. These data emphasize: (1) the diagnosis of TTP following BMT is uncertain because of the presence of multiple BMT-associated complications. (2) The outcome of patients with TTP-like syndromes following BMT is poor. (3) Urgent intervention with plasma exchange when TTP is suspected following BMT may not always be appropriate. Alternative explanations for the signs and symptoms should be considered and treated aggressively. Bone Marrow Transplantation (2001) 27, 641–646.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Clark WF, Rock GA, Buskard N et al. Therapeutic plasma exchange: an update from the Canadian Apheresis Group Ann Int Med 1999 131: 453–462
Amorosi EL, Ultmann JE . Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature Medicine 1966 45: 139–159
George JN, El-Harake MA . Thrombocytopenia due to enhanced platelet destruction by nonimmunologic mechanisms. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds).Williams Hematology McGraw-Hill: New York 1995; pp 1290–1314
Rock GA, Shumak KH, Buskard NA et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura New Engl J Med 1991 325: 393–397
Thompson CE, Damon LE, Ries CA, Linker CA . Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic Blood 1992 80: 1890–1895
George JN . How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Blood 2000 96: 1223–1229
Pettitt AR, Clark RE . Thrombotic microangiopathy following bone marrow transplantation Bone Marrow Transplant 1994 14: 495–504
Zeigler ZR, Shadduck RK, Nemunaitis J et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series Bone Marrow Transplant 1995 15: 247–253
Schriber JR, Herzig GP . Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Semin Hematol 1997 34: 126–133
Iacopino P, Pucci G, Arcese W et al. Gruppo Italiano Trapianto Midollo Osseo (GITMO). Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation Bone Marrow Transplant 1999 24: 47–51
Kanamori H, Maruta A, Sasaki S et al. Diagnostic value of hemostatic parameters in bone marrow transplantation-associated thrombotic microangiopathy Bone Marrow Transplant 1998 21: 705–709
Bell WR, Braine HG, Ness PM, Kickler TS . Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome New Engl J Med 1991 325: 398–403
Laszik Z, Silva F . Hemolytic-uremic syndrome, thrombotic thrombocytopenia purpura, and systemic sclerosis (systemic scleroderma). In: Jennett JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's Pathology of the Kidney Lippincott-Raven: Philadelphia 1998 pp 1003–1057
Matsuda Y, Hara J, Miyoshi H et al. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous marrow transplantation in young children Bone Marrow Transplant 1999 24: 919–923
Mitra D, Jaffe EA, Weksler B et al. Thrombotic thrombocytopenic purpura and sporadic hemolyticuremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells Blood 1997 89: 1224–1234
Dang CT, Magid MS, Weksler B et al. Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura Blood 1999 93: 1264–1270
Furlan M, Robles R, Galbusera M et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome New Engl J Med 1998 339: 1578–1584
Tsai H-M, Lian ECY . Antibodies to von-Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura New Engl J Med 1998 339: 1585–1594
van der Plas RM, Schiphorst ME, Huizinga EG et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura Blood 1999 93: 3798–3802
Oleksowicz L, Bhagwati N, DeLeon-Fernandez M . Deficient activity of vonWillebrand's factor-cleaving protease in patients with disseminated malignancies Cancer Res 1999 59: 2244–2250
Nürnberger W, Michelmann I, Burdach S, Göbel U . Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications Ann Hematol 1998 76: 61–65
Paquette RL, Tran L, Landaw EM . Thrombotic microangiopathy following allogenic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis Bone Marrow Transplant 1998 22: 351–357
Rizvi MA, Vesely SK, George JN et al. Plasma exchange complications in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Transfusion 2000 40: 896–901
Sarode R, McFarland JG, Flomenberg N et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation Bone Marrow Transplant 1995 16: 271–275
Milone J, Napal J, Bordone J et al. Complete response in severe thrombotic microangiopathy post bone marrow transplantation (BMT-TM) after multiple plasmaphereses BoneMarrow Transplant 1998 22: 1019–1021
Acknowledgements
This work was supported by the Hemostasis Research Fund of the University of Oklahoma Health Sciences Center. We thank Dr Georgia Vogelsang for continuing critical advice.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roy, V., Rizvi, M., Vesely, S. et al. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 27, 641–646 (2001). https://doi.org/10.1038/sj.bmt.1702849
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702849
Keywords
This article is cited by
-
Comparison of clinical characteristics of first-episode thrombotic thrombocytopenic purpura and TTP-like syndrome: a retrospective cohort study in a level I hematology center in China
Annals of Hematology (2023)
-
High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease
Bone Marrow Transplantation (2019)
-
Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies
Bone Marrow Transplantation (2018)
-
Post-bone marrow transplant thrombotic microangiopathy
Bone Marrow Transplantation (2016)
-
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma
BMC Nephrology (2014)